✦ LIBER ✦

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

✍ Scribed by Jonas Bergh; Tom Wiklund; Björn Erikstein; Elisabet Lidbrink; Henrik Lindman; Per Malmström; Pirkko Kellokumpu-Lehtinen; Nils-Olof Bengtsson; Gustaf Söderlund; Gun Anker; Erik Wist; Susanne Ottosson; Eeva Salminen; Per Ljungman; Harald Holte; Jonas Nilsson; Carl Blomqvist; Nils Wilking

Book ID: 117276084
Publisher: The Lancet
Year: 2000
Tongue: English
Weight: 114 KB
Volume: 356
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(00)02841-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised adjuvant trial comparing two

Randomised adjuvant trial comparing two dose intensities of epirubicin and cyclophosphamide (EC) in high-risk breast cancer

✍ G. Konecnv; C. Thomssen; M. Untch; S. Kahlert; W. Kuhn; D. Sattlet; E. Piche; A. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 140 KB

P84 High dose epirubicin and cyclophosph

P84 High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

✍ E. Galligioni; G. Cetto; O. Nascimben; A. Buonadonna; D. Crivellari; A. Molino; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 151 KB

349 High dose chemotherapy with hematopo

349 High dose chemotherapy with hematopoetic rescue as primary treatment for metastatic breast cancer: A randomised trial

✍ W.R. Bezwoda; L. Seymour; R.D. Dansey 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Multiple expression patterns of biopatho

Multiple expression patterns of biopathological markers as possible predictors of response to adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (HD EC) for high risk breast cancer

✍ C. Botti; M. Benevolo; F. Sciarretta; D. Giannarelli; S. Brenna; L. Trinca; P. P 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 306 KB

Tandem high-dose therapy with ifosfamide

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

✍ R. Haas; H. Schmid; U. Hahn; S. Hohaus; H. Goldschmidt; S. Murea; M. Kaufmann; M 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 898 KB

Comparison of rapidly cycled tandem high

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

✍ Ulrike Anneliese Nitz; Svjetlana Mohrmann; Johannes Fischer; Walter Lindemann; W 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 122 KB